FS Development Corp. II (NASDAQ:FSII) filed an 8-K this morning revealing that its shareholders have approved its combination with antiviral drug developer firm Pardes Biosciences.
Just 243,989 shares, or 1.2%, were redeemed in connection with the vote, removing roughly $2.4 million from its estimated trust of $201 million. ...READ MORE
Rocket Lab (NASDAQ:RKLB) announced this afternoon that it will be calling its warrant for shares as of January 21, 2022, based on the share trading above the $10.00 trigger price.
Warrantholders have until 5 pm EST on the 21st to exercise their warrants for shares at an exercise price of $11.50 or exercise them on a cashless basis. ...READ MORE
D&O insurance provider NFP, took a historical look at securities litigation within the SPAC asset class and prepared a report of their findings. Read on to see the results.
Andrew Pendergast, SPAC & GPL Practice Leader, NFP
Jonathan Abbott, FCAS, MAAA, Senior Vice-President, NFP
With the dramatic increase in SPAC D&O rates over the past 18 months we sought to answer whether SPACs are being targeted with securities litigation more frequently now than they have been historically, or if the percentage of SPACs being sued has remained relatively constant while the number of IPOs has increased. ...READ MORE
Participants will gain insight into the use of Special Purpose Acquisition Companies (SPACs) within Europe, Asia, and Latin America and the comparative opportunities and challenges of different regulatory frameworks in key jurisdictions. ...READ MORE
Participants will gain insight into the use of Special Purpose Acquisition Companies (SPACs) within Europe, Asia, and Latin America and the comparative opportunities and challenges of different regulatory frameworks in key jurisdictions. ...READ MORE
